Search - tctmd.com

Displaying 381 - 400 of 405

Sort: Relevancy | Date

Presentation TCT 2012

Keynote Lecture 1: What Is a “Heart Team” and Why Is it Essential for a Successful TAVR Program?

Presenter: Nicolo Piazza

October 26, 2012

Presentation TCT 2012

A “LIVE” Multi-disciplinary TAVR Heart Team Case Presentation(2)

Presenter: Tamim Nazif

October 26, 2012

Presentation TCT 2012

A “LIVE” Multi-disciplinary TAVR Heart Team Case Presentation

Presenter: Jean-Michel Paradis

October 26, 2012

Presentation TCT 2012

Patient Selection for TAVR: Risk Stratification, Important Patient Subgroups, and the Heart Team

Presenter: Scott Lim

October 24, 2012

Presentation TCT 2012

Why You Need a Multidisciplinary Heart Team: Case Scenario 1: Transcatheter Aortic Valve Replacement

Presenter: Mathew Williams

October 22, 2012

Presentation TCT 2012

The “Heart Team” Management Approach in Valvular Heart Disease: Components and Value Proposition - A Sustainable Model for the Future?

Presenter: A. Pieter Kappetein

October 22, 2012

News Industry News

FDA Approves Expanded Indication for Edwards Lifesciences' Transcatheter Valve

October 19, 2012

News Conference News ESC 2012

French, European Registries Add International Flavor to TAVR Assessment

August 29, 2012

News Daily News

Post-TAVR Transfusion Tied to Increased Mortality

August 16, 2012

News Daily News

JAMA Viewpoint: TAVR Promise Must Be Weighed Against Risks, Limitations

Yael L. Maxwell

August 09, 2012

News Daily News

TAVR Use Outstrips Evidence in Europe, BMJ Analysis Says

August 02, 2012

News Daily News

Access Site Complications Often Related to Closure Failure in TAVR Procedures

Caitlin E. Cox

July 30, 2012

News Daily News

Registry Shows Better Survival for Women vs. Men After TAVR

Caitlin E. Cox

July 19, 2012

CME

Updates on TAVR in Low-Risk Patients

CME

The Latest Data on Expanded Indications and What it Means for Referring Cardiologists

CME

TAVR: The Heart Team Approach

CME

TAVR-Moving to Low Risk: New Devices/Strategies to Reduce Complications

CME

TAVR Evolves: Are You and the Heart Team Ready?

CME

Advertisement

Keynote Lecture 1: What Is a “Heart Team” and Why Is it Essential for a Successful TAVR Program?

A “LIVE” Multi-disciplinary TAVR Heart Team Case Presentation(2)

A “LIVE” Multi-disciplinary TAVR Heart Team Case Presentation

Patient Selection for TAVR: Risk Stratification, Important Patient Subgroups, and the Heart Team

Why You Need a Multidisciplinary Heart Team: Case Scenario 1: Transcatheter Aortic Valve Replacement

The “Heart Team” Management Approach in Valvular Heart Disease: Components and Value Proposition - A Sustainable Model for the Future?

FDA Approves Expanded Indication for Edwards Lifesciences' Transcatheter Valve

French, European Registries Add International Flavor to TAVR Assessment

Post-TAVR Transfusion Tied to Increased Mortality

JAMA Viewpoint: TAVR Promise Must Be Weighed Against Risks, Limitations

TAVR Use Outstrips Evidence in Europe, BMJ Analysis Says

Access Site Complications Often Related to Closure Failure in TAVR Procedures

Registry Shows Better Survival for Women vs. Men After TAVR

Updates on TAVR in Low-Risk Patients

The Latest Data on Expanded Indications and What it Means for Referring Cardiologists

TAVR: The Heart Team Approach

TAVR-Moving to Low Risk: New Devices/Strategies to Reduce Complications

TAVR Evolves: Are You and the Heart Team Ready?

Optimizing the TAVR Patient Pathway

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content